Concepedia

Wenbing Shangguan

WS

Statistics

Publications

3

Citations

72

H-Index

3

Active since

2019

Affiliations

Zhejiang Chinese Medical University(Current)

Wenbing Shangguan is an author at Zhejiang Chinese Medical University specializing in oncology, medicine, and chemotherapy.

ORCID

Publications per year

2019–2025

3

Publications

3

Lin28b is involved in curcumin-reversed paclitaxel chemoresistance and associated with poor prognosis in hepatocellular carcinoma

Nan Tian, Wenbing Shangguan, Zuolin Zhou et al. · Journal of Cancer · 2019 · 35 citations · Full text

, , +17

<i>FoxD2-AS1</i>is a prognostic factor in glioma and promotes temozolomide resistance in a O<sup>6</sup>-methylguanine-DNA methyltransferase-dependent manner

Wenbing Shangguan, Xuyang Lv, Nan Tian · Korean Journal of Physiology and Pharmacology · 2019 · 22 citations · Full text

, , +17

NONO interacts with nuclear PKM2 and directs histone H3 phosphorylation to promote triple-negative breast cancer metastasis

Qi‐Xiang Li, Hongfei Ci, Pengpeng Zhao et al. · Journal of Experimental & Clinical Cancer Research · 2025 · 15 citations · Full text

, , +16

1–3 of 3